Michael Entzeroth

This inventor holds 23 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Dr. Karl Thomae Gmbh, Karl Thomae Gmbh, Karl Thomas Gmbh. Active years: 1991-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Entzeroth. Retrieved from https://idiyas.com/inventor/michael-entzeroth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 95.7

Average Co-Inventor Count = 6.8

ph-index = 11

Forward Citations = 605(Granted Patents)

Location History:

Apfingen, DE (1996 - 1999)
Warthausen, DE (1991 - 2000)
Meudon, FR (2002 - 2009)

Company Filing History:

Years Active: 1991-2009

Loading Chart...

Areas of Expertise:

Modified Amino Acids

Pharmaceutical Compositions

Benzimidazoles

Amino Acid Derivatives

Condensed Diazepinones

Phenylalkyl Derivatives

Angiotensin-II Antagonists

Imidazo[1,2-a]Pyridines

Substituted Benzimidazolyl Derivatives

Medicaments

Pharmaceutical Activity

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7498325 - Modified amino acids, pharmaceuticals containing these compounds and method for their production (2009-03-03),

2. 6344449 - Modified aminoacids, pharmaceuticals containing these compounds and method for their production (2002-02-05),

3. 6114390 - Amino acid derivatives, pharmaceutical compositions containing these (2000-09-05),

4. 5864043 - Benzimidazoles, medicaments containing these compounds and processes for (1999-01-26),

5. 5807875 - Amino acid derivatives, pharmaceutical compositions containing these (1998-09-15),

6. 5684029 - Benzimidazoles, pharmaceutical compositions containing these compounds (1997-11-04),

7. 5641772 - Condensed diazepinones, processes for preparing them and agents (1997-06-24),

8. 5616620 - Amino acid derivatives, pharmaceutical compositions containing these (1997-04-01),

9. 5614519 - (1-(2,3 or (1997-03-25),

10. 5610155 - Condensed diazepinones, processes for preparing them and agents (1997-03-11),

11. 5602127 - (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as (1997-02-11),

12. 5594003 - Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biph (1997-01-14),

13. 5591762 - Benzimidazoles useful as angiotensin-11 antagonists (1997-01-07),

14. 5587393 - Benzimidazoles, pharmaceutical compositions containing these compounds (1996-12-24),

15. 5565469 - Benzimidazoles and pharmaceutical compositions containing them (1996-10-15),

Title: The Innovative Mind of Michael Entzeroth

Introduction: Michael Entzeroth, a talented inventor hailing from Warthausen, Germany, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Michael Entzeroth's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Michael Entzeroth has established himself as a visionary in the tech industry. His work has been recognized globally for its ingenuity and practicality.

Collaborations: Throughout his career, Michael Entzeroth has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in interdisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: In conclusion, Michael Entzeroth's passion for innovation and his relentless drive to push the boundaries of technology have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire and shape the future of technological advancements.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]